Opportunity Information: Apply for RFA AG 22 027
The Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) program is a National Institutes of Health (NIH) funding opportunity designed to help early-career clinician-scientists pivot into aging- and geriatrics-focused research. It specifically targets physicians trained in medical or surgical specialties and early-career dentist-scientists who want to build a long-term research career centered on the health and care of older adults. The core purpose is career-launching: the program is meant to create a clear on-ramp into the aging research field by giving recipients the resources and structure to start producing early results, develop collaborations, and position themselves as future leaders in aging or geriatric research.
This opportunity uses the NIH R03 mechanism and is listed as "Clinical Trial Optional," meaning proposed projects may include clinical trials, but they are not required. The R03 is a small grant mechanism, and in the context of GEMSSTAR it is meant to fund focused, early-stage projects that can realistically be completed with limited funds and time. The emphasis is on generating pilot data and building research experience that can support the next step in an investigator's trajectory, such as a larger NIH award or a more extensive aging-related research program. In practice, the work supported under this announcement is expected to be transdisciplinary, encouraging investigators to cross traditional specialty boundaries and incorporate approaches from geriatrics, aging biology, health services research, behavioral science, epidemiology, implementation science, and related fields where appropriate.
The eligible applicant landscape is broad and includes many types of U.S.-based organizations and governments. Eligible applicants include state, county, and city or township governments; special district governments; and independent school districts. Public and state-controlled institutions of higher education, as well as private institutions of higher education, are eligible. The announcement also allows applications from federally recognized Native American tribal governments, as well as tribal organizations that are not federally recognized. Public housing authorities and Indian housing authorities may apply. Both nonprofit organizations with 501(c)(3) status and nonprofits without 501(c)(3) status are eligible, as are for-profit organizations (other than small businesses) and small businesses. The announcement also explicitly calls out additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible agencies of the federal government, regional organizations, and U.S. territories or possessions.
At the same time, the opportunity draws a firm line around non-U.S. institutions. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as applicant organizations. In addition, non-domestic components of U.S. organizations are not eligible to apply. However, "foreign components" are allowed as defined by the NIH Grants Policy Statement, which generally means a U.S. applicant organization may include certain types of foreign involvement or performance sites if they meet NIH's definition and requirements, even though a foreign institution cannot serve as the primary applicant.
From an administrative standpoint, this is a discretionary grant program under the health category and is associated with CFDA number 93.866. The funding opportunity is titled "Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)" and is identified as RFA-AG-22-027. The sponsoring agency is the NIH. The source data lists an original closing date of 2021-11-02 and a creation date of 2021-07-06. While the excerpt does not specify an award ceiling or the expected number of awards, the structure and intent of the R03 mechanism in this program strongly signal that awards are intended to be modest, targeted investments aimed at building momentum toward larger-scale aging research funding in the near future.
Overall, the GEMSSTAR program is best understood as a bridge for clinically trained specialists who want to develop a durable research niche in aging. It supports small, carefully scoped, cross-disciplinary projects that can produce publishable findings and preliminary data, strengthen an investigator's aging research network, and help establish the credibility and track record needed to compete for bigger aging- and geriatrics-focused grants later on.Apply for RFA AG 22 027
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2021-07-06.
- Applicants must submit their applications by 2021-11-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: U.S. Mission to NATO Public Affairs Annual Program Statement
Previous opportunity: Cooperative Agreement for Affiliated Partner with Rocky Mountains Cooperative Ecosystem Studies Unit
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 22 027
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 22 027) also looked into and applied for these:
| Funding Opportunity |
|---|
| Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed) Apply for RFA AG 22 022 Funding Number: RFA AG 22 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) Apply for PAR 21 263 Funding Number: PAR 21 263 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Apply for PAR 21 264 Funding Number: PAR 21 264 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) Apply for RFA HG 21 001 Funding Number: RFA HG 21 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed) Apply for RFA HG 21 002 Funding Number: RFA HG 21 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Making Health Care Safer in Ambulatory Care Settings and Long-term Care Facilities (R18) Apply for PA 21 267 Funding Number: PA 21 267 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) Apply for PA 22 047 Funding Number: PA 22 047 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) Apply for PAR 21 239 Funding Number: PAR 21 239 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18) Apply for PA 22 048 Funding Number: PA 22 048 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) Apply for RFA AI 21 050 Funding Number: RFA AI 21 050 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) Apply for RFA RM 21 025 Funding Number: RFA RM 21 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 021 Funding Number: RFA AG 22 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 22 015 Funding Number: RFA AG 22 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required) Apply for RFA AG 22 024 Funding Number: RFA AG 22 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) Apply for PAR 21 265 Funding Number: PAR 21 265 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Apply for PAR 21 276 Funding Number: PAR 21 276 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) Apply for PAR 21 267 Funding Number: PAR 21 267 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) Apply for PAR 21 258 Funding Number: PAR 21 258 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) Apply for PAR 21 266 Funding Number: PAR 21 266 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Data Management and Coordinating Center (DMCC) and a Collaborative Research Space for Translational Research on Exceptional Longevity (U24 Clinical Trial Not Allowed) Apply for RFA AG 22 023 Funding Number: RFA AG 22 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 22 027", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
